Incontinence Clinical Trial
Official title:
The Effect of Solifenacin on Post Void Dribbling in Women: A Randomized Controlled Multicenter Trial
This is a double-blind, randomized, controlled, parallel design (n=140) study with the purpose of measuring the efficacy of Solifenacin 5mg in the treatment of women with Post Void Dribbling (PVD).
This investigation will have a double-blind, randomized, and controlled, parallel design
with the % reduction in PVD episodes (events) as the primary endpoint.
Secondary endpoints will include:
1. The % of patients with at least a 50% reduction in PVD episodes.
2. Patient's perspective of the impact of their disease, which will be captured using the
Pelvic Floor Distress Inventory (PFDI), and another questionnaire that asks about
urinary symptoms and quality of life.
We will compare Solifenacin 5 mg to placebo. 140 subjects will be enrolled, with 70 subjects
in each arm. The treatment group will receive 5mg of Solifenacin daily for 12 weeks.
Astellas Pharma will be supplying both drug and placebo, they will be prepackaged and
numbered. The Pharmaceutical Research Center (PRC) will randomly assign subjects into the
treatment vs. placebo group blinding both the subjects and investigators
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02835846 -
Investigation of the Effect of the Female Urinary Microbiome on Incontinence
|
Phase 4 | |
Recruiting |
NCT02978638 -
Electrical Stimulation for Continence After Spinal Cord Injury
|
N/A | |
Completed |
NCT01978210 -
Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism
|
N/A | |
Completed |
NCT00972998 -
Study to Examine the Effect of Coated Phenylephrine Suppositories on Anal Pressure in Healthy Subjects
|
Phase 1/Phase 2 | |
Completed |
NCT01036035 -
Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04110821 -
Quality of Life After Conservative and Surgical Treatment of Pelvic Organ Prolapse
|
||
Recruiting |
NCT05826691 -
Benign Prostate Surgery and QOL and Sexual Function
|
||
Recruiting |
NCT05362292 -
TReating Incontinence for Underlying Mental and Physical Health
|
Phase 4 | |
Recruiting |
NCT05935371 -
Consequences of Obstetric Anal Sphincter Injuries on Maternal Psychology and Relationship Experience
|
||
Completed |
NCT02554201 -
Efficacy of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction
|
N/A | |
Completed |
NCT01486706 -
Efficacy and Safety of Gabapentin in Treating Overactive Bladder
|
Phase 2/Phase 3 | |
Completed |
NCT00617786 -
CPT Testing for Sacral Neuromodulation Outcomes
|
N/A | |
Completed |
NCT02633592 -
Seated Evaluation of Anorectal funcTion by High Resolution Anorectal Manometry
|
N/A | |
Completed |
NCT01747343 -
Toilet Training Toddlers and Preschoolers
|
N/A | |
Recruiting |
NCT02091947 -
Efficacy of Functional Magnetic Stimulation in Urinary Incontinence
|
Phase 2 | |
Completed |
NCT01108367 -
Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate (HoLEP)
|
N/A | |
Completed |
NCT04924218 -
Evaluation of the Effect of Endoscopic Urethral Procedures Applied After Radical Prostatectomy on Urinary Incontinence
|
N/A | |
Recruiting |
NCT04010292 -
Enhancing Patient Recall in Urogynecologic Surgery
|
N/A | |
Completed |
NCT05106010 -
The Effect of Yoga on Decreasing Risk of Fall-Related Injury in Peri and Post-Menopausal
|
||
Completed |
NCT04867876 -
Qol Following Management for Pediatric UI
|
N/A |